EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Development of an Untargeted LC-MS Metabolomics Method with Postcolumn Infusion for Matrix Effect Monitoring in Plasma and Feces

Pingping Zhu iD, Anne-Charlotte Dubbelman iD, Christie Hunter, Michele Genangeli, Naama Karu, Amy Harms iD, Thomas Hankemeier iD

Journal of the American Society for Mass Spectrometry · 2024-03-06 · 35 (3) · 590-602

DOI: 10.1021/jasms.3c00418 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, published online on 2024-02-21. Written by Pingping Zhu and 6 co-authors. Institution: Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2333 CC, Netherlands. Major MEDLINE topics: Liquid Chromatography-Mass Spectrometry, Tandem Mass Spectrometry. Cited 20 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: China Scholarship Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Untargeted metabolomics based on reverse phase LC-MS (RPLC-MS) plays a crucial role in biomarker discovery across physiological and disease states. Standardizing the development process of untargeted methods requires paying attention to critical factors that are under discussed or easily overlooked, such as injection parameters, performance assessment, and matrix effect evaluation. In this study, we developed an untargeted metabolomics method for plasma and fecal samples with the optimization and evaluation of these factors. Our results showed that optimizing the reconstitution solvent and sample injection amount was critical for achieving the balance between metabolites coverage and signal linearity. Method validation with representative stable isotopically labeled standards (SILs) provided insights into the analytical performance evaluation of our method. To tackle the issue of the matrix effect, we implemented a postcolumn infusion (PCI) approach to monitor the overall absolute matrix effect (AME) and relative matrix effect (RME). The monitoring revealed distinct AME and RME profiles in plasma and feces. Comparing RME data obtained for SILs through postextraction spiking with those monitored using PCI compounds demonstrated the comparability of these two methods for RME assessment. Therefore, we applied the PCI approach to predict the RME of 305 target compounds covered in our in-house library and found that targets detected in the negative polarity were more vulnerable to the RME, regardless of the sample matrix. Given the value of this PCI approach in identifying the strengths and weaknesses of our method in terms of the matrix effect, we recommend implementing a PCI approach during method development and applying it routinely in untargeted metabolomics.

Subjects

MeSH terms (MEDLINE)

Liquid Chromatography-Mass SpectrometryTandem Mass SpectrometryChromatography, LiquidMetabolomicsFeces

Author keywords

fecesmatrix effectmethod developmentplasmapostcolumn infusionuntargeted metabolomics

Authors and institutions

  • Metabolomics and Analytics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden 2333 CC, Netherlands.
  • Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3584 CM, The Netherlands.
  • SCIEX, Redwood City, California 94065, United States.

ORCID profiles: Pingping Zhu, Anne-Charlotte Dubbelman, Amy Harms, Thomas Hankemeier

Funding

  • China Scholarship Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Cite

APA

Zhu, P., Dubbelman, A. C., Hunter, C., Genangeli, M., Karu, N., Harms, A., & Hankemeier, T. (2024). Development of an Untargeted LC-MS Metabolomics Method with Postcolumn Infusion for Matrix Effect Monitoring in Plasma and Feces. Journal of the American Society for Mass Spectrometry, 35(3), 590-602. https://doi.org/10.1021/jasms.3c00418

Vancouver

Zhu P, Dubbelman AC, Hunter C, Genangeli M, Karu N, Harms A, et al. Development of an Untargeted LC-MS Metabolomics Method with Postcolumn Infusion for Matrix Effect Monitoring in Plasma and Feces. Journal of the American Society for Mass Spectrometry. 2024;35(3):590-602. doi:10.1021/jasms.3c00418

BibTeX
@article{Zhu2024,
  author = {Zhu, Pingping and Dubbelman, Anne-Charlotte and Hunter, Christie and Genangeli, Michele and Karu, Naama and Harms, Amy and Hankemeier, Thomas},
  title = {Development of an Untargeted LC-MS Metabolomics Method with Postcolumn Infusion for Matrix Effect Monitoring in Plasma and Feces},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2024},
  volume = {35},
  number = {3},
  pages = {590--602},
  doi = {10.1021/jasms.3c00418}
}
Start for free →